JAK2V617F mRNA metabolism in myeloproliferative neoplasm cell lines

被引：0
|
作者：
P Nauroy
F Delhommeau
F Baklouti
机构：
[1] mRNA Metabolism in Normal and Pathological Cells,
[2] CNRS UMR 5534,undefined
[3] Université Lyon 1,undefined
[4] Sorbonne Universités,undefined
[5] UPMC Univ Paris 06,undefined
[6] GRC no. 07,undefined
[7] Groupe de Recherche Clinique sur les Myéloproliférations Aiguës et Chroniques MyPAC,undefined
[8] AP-HP,undefined
[9] Hôpital Saint-Antoine,undefined
[10] Laboratoire d'Hématologie,undefined
[11] Sorbonne Universités,undefined
[12] UPMC Univ Paris 06,undefined
[13] UMR_S 938,undefined
[14] CDR Saint-Antoine,undefined
[15] INSERM,undefined
[16] UMR_S 938,undefined
[17] CDR Saint-Antoine,undefined
[18] Current address: Institut de Génomique Fonctionnelle de Lyon,undefined
[19] Ecole Normale Supérieure,undefined
[20] Lyon,undefined
[21] France,undefined
来源：
Blood Cancer Journal | 2014年 / 4卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：e222 / e222
相关论文
共 50 条
  • [31] The JAK2V617F negative erythrocytosis: A distinctive myeloproliferative syndrome?
    Di Gaetano, R.
    Zanotto, D.
    Belvini, D.
    Salviato, R.
    Pierobon, F.
    De Biasi, E.
    Radossi, P.
    Risato, R.
    Roveroni, G.
    Sartori, R.
    Tassinari, C.
    Toffano, N.
    Tagariello, G.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 168 - 168
  • [32] Identification of JAK2V617F Mutation on Myeloproliferative Disorders in Medan
    Anggraini, Dwi Rita
    Hidayat
    Sitorus, Mega Sari
    PROCEEDINGS OF THE 1ST PUBLIC HEALTH INTERNATIONAL CONFERENCE (PHICO 2016), 2016, 1
  • [33] The Study of Thrombosis in JAK2V617F Mutated Myeloproliferative Neoplasms
    Bai, Jie
    Zhang, Yuhui
    Wang, Yingshao
    Teng, Guangshuai
    Wang, Yan
    Du, Chenxiao
    Chen, Yafang
    Zhang, Huiqin
    Li, Yanqi
    Fu, Lixia
    Zhang, Lei
    Zhou, Yuan
    BLOOD, 2019, 134
  • [34] Thrombosis in myeloproliferative neoplasia Influence of the mutation JAK2V617F
    Guy, Alexandre
    James, Chloe
    M S-MEDECINE SCIENCES, 2019, 35 (8-9): : 651 - 658
  • [35] JAK2V617F impairs lymphoid differentiation in myeloproliferative neoplasms
    Choi, Daniel C.
    Messali, Nassima
    Uda, Narasimha Rao
    Abu-Zeinah, Ghaith
    Kermani, Pouneh
    Yabut, Maria Mia
    Lischer, Heidi E. L.
    Tokumori, Franco Castillo
    Erdos, Katie
    Lehmann, Thomas
    Sobas, Marta
    Rao, Tata Nageswara
    Scandura, Joseph M.
    LEUKEMIA, 2024, 38 (11) : 2487 - 2491
  • [36] JAK2V617F mutation detection in myeloproliferative disorders (MPD)
    Bakkus, M. H. C.
    Trullemans, F.
    Demanet, C.
    De Waele, M.
    ACTA CLINICA BELGICA, 2006, 61 (02): : 110 - 110
  • [37] JAK2V617F allele burden in patients with myeloproliferative neoplasms
    Alshemmari, Salem H.
    Rajaan, Reshmi
    Ameen, Reem
    Al-Drees, Mohammad A.
    Almosailleakh, Marwa R.
    ANNALS OF HEMATOLOGY, 2014, 93 (05) : 791 - 796
  • [38] Cell competition between wild-type and JAK2V617F mutant cells in a murine model of a myeloproliferative neoplasm
    Castiglione, Melissa
    Zhang, Haotian
    Kaushansky, Kenneth
    Zhan, Huichun
    EXPERIMENTAL HEMATOLOGY, 2021, 100 : 52 - 62
  • [39] DISTINCT EFFECTS OF RUXOLITINIB AND INTERFERON-ALPHA ON JAK2V617F MYELOPROLIFERATIVE NEOPLASM HEMATOPOIETIC STEM CELL POPULATIONS
    Bywater, Megan
    Austin, Rebecca
    Straube, Jasmin
    Mullally, Ann
    Milson, Michael
    Lane, Steven
    EXPERIMENTAL HEMATOLOGY, 2019, 76 : S60 - S60
  • [40] HH-002 Effectively Suppresses Myeloproliferative Neoplasm Phenotypes in JAK2V617F Transgenic Mice
    Ho, Wan-Ting
    Zhao, Wanke
    Hallenbeck, Paul
    Rong, Frank
    Zhao, Zhizhuang Joe
    BLOOD, 2015, 126 (23)
12345